Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
3.182
+0.062 (1.99%)
At close: Apr 28, 2026, 4:00 PM EDT
3.200
+0.018 (0.57%)
After-hours: Apr 28, 2026, 4:00 PM EDT
Lisata Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 0.17 | 1 | - | - | - | |
| Revenue Growth (YoY) | -83.00% | - | - | - | - | |
| Gross Profit | 0.17 | 1 | - | - | - | |
| Selling, General & Admin | 10.43 | 12.08 | 12.97 | 14.14 | 11.47 | |
| Research & Development | 7.95 | 11.33 | 12.73 | 13.07 | 17.58 | |
| Operating Expenses | 18.38 | 23.41 | 25.71 | 27.21 | 29.05 | |
| Operating Income | -18.21 | -22.41 | -25.71 | -27.21 | -29.05 | |
| Interest & Investment Income | 0.81 | 1.88 | 2.72 | 1.05 | 0.15 | |
| Other Non Operating Income (Expenses) | -0.05 | -0.16 | -0.09 | -0.06 | -0.08 | |
| EBT Excluding Unusual Items | -17.45 | -20.68 | -23.07 | -26.21 | -28.97 | |
| Gain (Loss) on Sale of Assets | -0.1 | -0.1 | -0.1 | -0.1 | - | |
| Pretax Income | -17.55 | -20.78 | -23.17 | -56.7 | -28.97 | |
| Income Tax Expense | -0.96 | -0.8 | -2.33 | -2.48 | -1.51 | |
| Earnings From Continuing Operations | -16.59 | -19.99 | -20.84 | -54.23 | -27.47 | |
| Net Income to Company | -16.59 | -19.99 | -20.84 | -54.23 | -27.47 | |
| Net Income | -16.59 | -19.99 | -20.84 | -54.23 | -27.47 | |
| Net Income to Common | -16.59 | -19.99 | -20.84 | -54.23 | -27.47 | |
| Shares Outstanding (Basic) | 9 | 8 | 8 | 5 | 4 | |
| Shares Outstanding (Diluted) | 9 | 8 | 8 | 5 | 4 | |
| Shares Change (YoY) | 4.30% | 3.17% | 55.85% | 40.46% | 258.29% | |
| EPS (Basic) | -1.91 | -2.40 | -2.58 | -10.47 | -7.45 | |
| EPS (Diluted) | -1.91 | -2.40 | -2.58 | -10.47 | -7.45 | |
| Free Cash Flow | -15.98 | -19.36 | -20.03 | -21.46 | -22.31 | |
| Free Cash Flow Per Share | -1.84 | -2.32 | -2.48 | -4.14 | -6.05 | |
| Gross Margin | 100.00% | 100.00% | - | - | - | |
| Operating Margin | -10711.18% | -2240.90% | - | - | - | |
| Profit Margin | -9756.47% | -1998.50% | - | - | - | |
| Free Cash Flow Margin | -9398.24% | -1935.60% | - | - | - | |
| EBITDA | -18.06 | -22.24 | -25.52 | -27.14 | -29 | |
| D&A For EBITDA | 0.15 | 0.17 | 0.19 | 0.07 | 0.06 | |
| EBIT | -18.21 | -22.41 | -25.71 | -27.21 | -29.05 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.